Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

07/30/2021 | 09:23am EDT


© MT Newswires 2021
All news about ERYTECH PHARMA S.A.
09/17ERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conferenc..
PU
09/15ERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conferenc..
AQ
09/13European ADRs Rise 1% Monday as Energy Giants Gain, Pharma Retreats
MT
09/07GLOBAL MARKETS LIVE : Ryanair, Hyundai, Adecco, Goldman Sachs, JD.com...
09/06ERYTECH PHARMA S A : to Present at the H.C. Wainwright 23rd Annual Global Invest..
GL
09/03ERYTECH PHARMA S A : Webinar on Eryaspase in Pancreatic Cancer (September 1, 202..
PU
08/31GLOBAL MARKETS LIVE : EssilorLuxottica, PayPal, Volkswagen, Holcim, Apple....
08/30ERYTECH PHARMA S A : to Participate in the Citi 16th Annual BioPharma Conference
GL
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
08/25European ADRs Slightly Higher Wednesday Morning
MT
More news
Financials
Sales 2021 8,21 M 9,63 M 9,63 M
Net income 2021 -60,0 M -70,4 M -70,4 M
Net Debt 2021 16,1 M 18,9 M 18,9 M
P/E ratio 2021 -1,33x
Yield 2021 -
Capitalization 144 M 169 M 168 M
EV / Sales 2021 19,4x
EV / Sales 2022 5,24x
Nbr of Employees 206
Free-Float 88,9%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | ERYP | FR0011471135 | MarketScreener
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 5,18 €
Average target price 14,50 €
Spread / Average Target 180%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-27.14%169
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850